The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease
Clinical trial NCT02453607 · UNKNOWN
Trial details
- NCT number
- NCT02453607
- Sponsor
- Ernest Seidman
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2014-11-17
- Primary completion
- 2019-06-30
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.